May - 2012
| Previous Next | Showing Journal 4 of 21 |
Effect of Empirical Treatment With Moxifloxacin and Meropenem vs Meropenem on Sepsis-Related Organ Dysfunction in Patients With Severe Sepsis: A Randomized TrialGerman Study Group Competence Network Sepsis (SepNet) JAMA, 2012, 307(22):doi:10.1001/jama.2012.5833 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
May |
Previous Comments
No Comments yet.
Comment
This prospective RCT by the German SepNet investigators showed early meropenem and moxifloxacin vs meropenem alone did not improve mortality in severe sepsis and septic shock